EXSERVAN
Total Payments
$23,156
Transactions
39
Doctors
33
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $11,056 | 29 | 29 |
| 2021 | $12,100 | 10 | 6 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,760 | 20 | 98.3% |
| Food and Beverage | $395.97 | 19 | 1.7% |
Top Doctors Receiving Payments for EXSERVAN — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Neurology | Pomona, CA | $16.84 | 1 |
| , PA | Physician Assistant | Pomona, CA | $16.84 | 1 |
| , MD | Neurology | Arcadia, CA | $16.47 | 1 |
| , MD | Neurology | Los Angeles, CA | $14.61 | 1 |
| , M.D | Neurology | Apple Valley, CA | $14.50 | 1 |
| , M.D | Neurology | Whittier, CA | $14.26 | 1 |
| , M.D | Neurology | Whittier, CA | $14.25 | 1 |
| , D.O | Neurology | Upland, CA | $14.21 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $23,156
- Total Doctors 33
- Transactions 39
About EXSERVAN
EXSERVAN is a drug associated with $23,156 in payments to 33 healthcare providers, recorded across 39 transactions in the CMS Open Payments database. The primary manufacturer is MITSUBISHI TANABE PHARMA AMERICA, INC..
Payment data is available from 2021 to 2023. In 2023, $11,056 was paid across 29 transactions to 29 doctors.
The most common payment nature for EXSERVAN is "Consulting Fee" ($22,760, 98.3% of total).